Vanguard Group Inc Tenaya Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.57 Trillion
  • Q4 2025

A detailed history of Vanguard Group Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,560,108 shares of TNYA stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,560,108
Previous 5,064,857 69.01%
Holding current value
$11.6 Million
Previous $7.75 Million 50.23%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026
BUY
$1.26 - $2.1 $4.4 Million - $7.34 Million
3,495,251 Added 69.01%
8,560,108 $11.6 Million
Q3 2025

Nov 07, 2025
BUY
$0.58 - $1.66 $179,527 - $513,819
309,530 Added 6.51%
5,064,857 $7.75 Million
Q2 2025

Aug 11, 2025
BUY
$0.39 - $0.69 $262,585 - $464,573
673,295 Added 16.49%
4,755,327 $2.9 Million
Q1 2025

May 09, 2025
BUY
$0.44 - $1.52 $356,394 - $1.23 Million
809,988 Added 24.75%
4,082,032 $2.33 Million
Q4 2024

Feb 11, 2025
BUY
$1.23 - $3.78 $72,418 - $222,555
58,877 Added 1.83%
3,272,044 $4.68 Million
Q3 2024

Nov 13, 2024
BUY
$1.93 - $3.99 $94,378 - $195,114
48,901 Added 1.55%
3,213,167 $6.2 Million
Q2 2024

Aug 13, 2024
BUY
$2.72 - $4.99 $819,672 - $1.5 Million
301,350 Added 10.53%
3,164,266 $9.81 Million
Q1 2024

May 10, 2024
BUY
$2.88 - $6.8 $1.16 Million - $2.74 Million
403,472 Added 16.41%
2,862,916 $15 Million
Q4 2023

Feb 14, 2024
BUY
$1.73 - $3.39 $504,426 - $988,442
291,576 Added 13.45%
2,459,444 $7.97 Million
Q3 2023

Nov 14, 2023
BUY
$2.55 - $5.65 $429,646 - $951,962
168,489 Added 8.43%
2,167,868 $5.53 Million
Q2 2023

Aug 14, 2023
BUY
$2.64 - $7.64 $347,825 - $1.01 Million
131,752 Added 7.05%
1,999,379 $11.7 Million
Q1 2023

May 15, 2023
BUY
$1.92 - $3.59 $482,709 - $902,565
251,411 Added 15.56%
1,867,627 $5.32 Million
Q4 2022

Feb 10, 2023
BUY
$1.68 - $3.19 $933,493 - $1.77 Million
555,651 Added 52.39%
1,616,216 $3.25 Million
Q3 2022

Nov 14, 2022
SELL
$2.9 - $5.88 $8,615 - $17,469
-2,971 Reduced 0.28%
1,060,565 $3.08 Million
Q2 2022

Aug 12, 2022
SELL
$5.01 - $14.12 $110,856 - $312,433
-22,127 Reduced 2.04%
1,063,536 $5.99 Million
Q1 2022

May 13, 2022
BUY
$9.41 - $19.3 $4.98 Million - $10.2 Million
528,845 Added 94.98%
1,085,663 $12.8 Million
Q4 2021

Feb 14, 2022
BUY
$18.41 - $29.58 $991,010 - $1.59 Million
53,830 Added 10.7%
556,818 $10.6 Million
Q3 2021

Nov 12, 2021
BUY
$15.35 - $26.66 $7.72 Million - $13.4 Million
502,988 New
502,988 $10.4 Million

Others Institutions Holding TNYA

# of Institutions
100
Shares Held
42.1M
Call Options Held
313K
Put Options Held
61.1K
View Full List

About Tenaya Therapeutics, Inc.

TNYA Quotes by TradingView
  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $56.3M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email